Addiction Medicine may be on track to become a board certified specialty in the future, differentiating itself from the current ABMS-approved subspecialty of Addiction Psychiatry. How has the advancing field reached this stage, and what does it mean for us and our patients? Additionally, what will an Addiction Specialist be able to do that an Addiction Psychiatrist cannot, and vice-versa? Dr. Kevin Kunz, Interim President of the American Board of Addiction Medicine, remarks on this developmental trend from the field. Hosted by Dr. Stu Gitlow.
Addiction Medicine Board Certification: Shifting Practice?
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Addiction Medicine may be on track to become a board certified specialty in the future, differentiating itself from the current ABMS-approved subspecialty of Addiction Psychiatry. How has the advancing field reached this stage, and what does it mean for us and our patients? Additionally, what will an Addiction Specialist be able to do that an Addiction Psychiatrist cannot, and vice-versa? Dr. Kevin Kunz, Interim President of the American Board of Addiction Medicine, remarks on this developmental trend from the field. Hosted by Dr. Stu Gitlow.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
Updates From the 7th World Symposium Task Force
1.00 credits
<p><span data-contrast="auto" xml:lang="EN-US">Updates From the 7th World Symposium Task Force</span><span data-ccp-props='{"201341983":0,"335559738":210,"335559739":210,"335559740":240}'> </span></p>
MinuteCE®
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
1.00 credits
<p>Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D</p>
MinuteCE®
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
0.75 credits
<p><span data-contrast="auto" style="list-style-type: disc;" xml:lang="EN-US">Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies</span></p>
MinuteCE®
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
0.75 credits
<p><span data-contrast="none" style="list-style-type: disc;" xml:lang="EN-US">The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC</span></p>
NeuroFrontiers
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
<p>Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms</p>
NeuroFrontiers
From Diagnosis to Treatment: Challenges in Glioblastoma Care
<p>From Diagnosis to Treatment: Challenges in Glioblastoma Care</p>
Advances in Women's Health
Improving the IUD Experience: Evidence-Based Pain Management Approaches
<p>Improving the IUD Experience: Evidence-Based Pain Management Approaches</p>
Clinician's Roundtable
Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder
<p>Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?